Cannabis
Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced today its participation in the XLIV International Course of Internal Medicine conference, which took place from July 3-6 in Monterrey, Mexico. Organized by the Mexican College of Internal Medicine, Khiron was the only cannabis company to participate in this year’s conference, where it joined over 2000 physicians and medical specialists to inform, educate and discuss medical cannabis knowledge and developments.
On July 3rd, Khiron opened the conference with a one-hour session covering global research and insight on the safe and responsible prescription of medical cannabis, presented by Dr. Maria Fernanda Arboleda, International Director of Medical Services at Khiron Life Sciences and medical cannabis expert. The Company also hosted a booth at the conference from July 4-6, where attendees had the opportunity to learn about the Khiron brand, explore its products, and engage in interactive discussion with Khiron’s medical team.
Luis Chaves, Khiron’s country manager for Mexico, stated: “At Khiron, we have been continually committed to helping doctors and health care professionals provide safe and effective medical cannabis treatment options. As one of Mexico’sforemost platforms for advancing the conversation around medical cannabis, our participation in the XLIV International Course of Internal Medicine furthers our stated mission to increase awareness on the benefits of cannabis for medical use, and to introduce medicinal cannabis products across Mexico and Latin America.”
Combined with Khiron’s ongoing medical education efforts to engage physicians across the country, the Company’s presence at the XLIV International Course of Internal Medicine conference further builds upon its close relationship with medical associations and health care professionals across the LatAm region. Khiron has previously received the endorsement of the Mexican College of Internal Medicine for KhironMed, the Company’s Medical Cannabis Symposium held in Mexico City last February 2019, as well as for its schedule of medical education symposium and activities taking place in Mexico this year.
Dr. Roberto Lopez, president of the Mexican College of Internal Medicine, commented: “As scientific research continues to support the use of cannabis-based products for various medical conditions, the XLIV International Course of Internal Medicine aims to train health leaders in the safe use and prescription of medicinal cannabis. We were incredibly excited to have Khiron join us and participate in this year’s conference.”
SOURCE Khiron Life Sciences Corp.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis1 week ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan4 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf4 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis4 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care